WMSA
CALT

Weiss Multi-Strategy Advisers’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio CALT Stock Details CALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,023
Closed -$233K – 702
2020
Q2 		$233K Buy
+10,023
New +$199K 0.01% 506

Other funds holding CALT

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Weiss Multi-Strategy Advisers's CALT Position: Q3 2020 in Review

Weiss Multi-Strategy Advisers sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q3 2020, closing a stake of 10,023 shares — an estimated $233K sold.

Weiss Multi-Strategy Advisers first reported a position in CALT in Q2 2020 and held it in 1 quarter. The position peaked at $233K in Q2 2020. 16 funds tracked by Wall St. Rank hold CALT as of Q3 2020.

  • Weiss Multi-Strategy Advisers reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q3 2020 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 10,023 Calliditas Therapeutics AB American Depositary Shares shares in Q3 2020, an estimated $233K.
  • Weiss Multi-Strategy Advisers first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q2 2020 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's Calliditas Therapeutics AB American Depositary Shares position peaked at $233K in Q2 2020.
  • 16 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q3 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2020, filed 16 Nov 2020.